Marijuana Controlled Substances Cannabis Cannabis Legislation Narcotics Control DEA Decriminalization Marijuana Legislation Cannabis Regulation NDPS Act Enforcement Agencies Cannabis Rescheduling Drug Possession Laws Drug Scheduling Drug Legalization Enforcement Drug Classification Medical Marijuana Medicinal Cannabis Drug Enforcement Vaping Regulations Controlled Substances Act Drug Laws Cannabis Legalization Recreational Cannabis Legalization Marijuana Legalization Marijuana Reclassification DEA Reclassification DEA's Marijuana Reclassification Law Enforcement Narcotics Penalties Marijuana Classification Medical Cannabis Fentanyl Regulation of Pharmaceuticals Regulation Illicit Drugs
Want to see what podcasts are saying about this topic? Search across 125K+ podcasts. Explore Radar
The agency says the move will target concentrated and lab‑made 7‑hydroxymitragynine products because regulators link them to rising poisonings and local overdose deaths.
